{"text_format":"1","workbook":"xlsx","n_sheets":4,"sheets":["1999_00-Deutsch","CF Deutsch","CF Englisch","CF_AR"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":0,"defined_names":18,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1904"}

{"sheet":"1999_00-Deutsch","index":0,"n_rows":68,"n_cols":9,"rows_kept":68,"cut":false,"hidden":true,"merged":[]}
["Asclepion-Meditec AG"]
["Kapitalflussrechnung"]
["für die Geschäftsjahre zum 30. September 2000 und 2001"]
[]
[null,null,null,null,null,null,1.95583]
[null,null,null,null,null,null,"30. September",null,"30. September"]
[null,null,null,null,null,null,2000,null,2001]
[null,null,null,null,null,null,"TDM",null,"TDM"]
[]
[]
["Cash Flow aus laufender Geschäftstätigkeit:"]
[null,"Jahresüberschuss ",null,null,null,null,3827,null,-14865]
[null,"Anpassung zur Überleitung des Jahresüberschusses/Jahresfehlbetrags"]
[null,"zur Nettoveränderung der liquiden Mittel aus laufender Geschäftstätigkeit:"]
[null,null,"Abschreibungen",null,null,null,2273,null,2334]
[null,null,"Verluste /(Gewinne) aus Abgang von Sachanlagevermögen",null,null,null,-72,null,85]
[null,null,"Zahlungsunwirksame Erträge",null,null,null,0,null,{"$f":"-(4418+5400+4271+794)","v":-14883}]
[null,null,"Zuführung zu Wertberichtigungen",null,null,null,0,null,13190]
[null,null,"Auswirkung von Wechselkursänderungen",null,null,null,-1815,null,0]
[null,null,"Anpassung Ertragsteuern für Kosten im Zusammenhang mit dem Börsengang",null,null,null,5291,null,0]
[null,null,"Latente Steuern",null,null,null,-706,null,{"$f":"-4271+505","v":-3766}]
[null,null,"Veränderung bei Vermögensgegenständen und Verbindlichkeiten:"]
[null,null,"Erhöhung der Forderungen an verbundene Unternehmen","(Erhöhung) / Verringerung der Forderungen"]
[null,null,null,null,"und Dritte",null,-23032,null,-3319]
[null,null,"Erhöhung Vorräte","Erhöhung Vorräte",null,null,-1529,null,-8688]
[null,null,"(Erhöhung) / Verringerung der aktiven Rechnungs-","(Erhöhung) / Verringerung der aktiven Rechnungs-"]
[null,null,null,null,"abgrenzung und sonstiger Vermögensgegenstände",null,-1432,null,-4835]
[null,null,"(Erhöhung) / Verringerung aktivierter Börseneinführungskosten","Erhöhung aktivierter Börseneinführungskosten",null,null,500,null,0]
[null,null,"Erhöhung / (Verringerung) der Verbindlichkeiten","Erhöhung / (Verringerung) der Verbindlichkeiten"]
[null,null,null,null,"an verbundene Unternehmen und Dritte",null,1616,null,{"$f":"-523","v":-523}]
[null,null,"Erhöhung / (Verringerung) der Rückstellungen, passiven ","Erhöhung / (Verringerung) der Rückstellungen, passiven "]
[null,null,null,null,"Rechnungsabgrenzungen und sonstigen Verbindlichkeiten",null,3088,null,1311]
[null,null,null,null,"Gesamte Anpassungen",null,{"$f":"SUM(G15:G32)-1","v":-15819},null,{"$f":"SUM(I15:I32)","v":-19094}]
[null,null,null,"    Netto-Kapitalzufluss (-abfluss) aus laufender Geschäftstätigkeit","Netto-Kapitalabfluss aus laufender Geschäftstätigkeit",null,{"$f":"+G12+G33","v":-11992},null,{"$f":"+I12+I33","v":-33959}]
["Cash Flow aus der Investitionstätigkeit:"]
[null,"Erwerb von Sachanlagevermögen",null,null,null,null,-2255,null,-17862]
[null,"Erlöse aus dem Verkauf von Sachanlagevermögen",null,null,null,null,125,null,14]
[null,"Erwerb von Minderheitenbeteiligungen an nahestehenden Unternehmen",null,null,null,null,-3548,null,-1301]
[null,"Gewährung von Darlehen",null,null,null,null,-113,null,-6984]
[null,null,null,null,"Netto-Kapitalabfluss aus Investitionstätigkeit",null,{"$f":"SUM(G36:G39)","v":-5791},null,{"$f":"SUM(I36:I39)","v":-26133}]
["Cash Flow aus Finanzierungstätigkeit:"]
[null,"Einnahmen aus der Ausgabe von Stückaktien",null,null,null,null,113994,null,0]
[null,"Aufnahme kurzfristiger Kredite",null,null,null,null,86,null,3162]
[null,"Rückzahlung kurzfristiger Kredite",null,null,null,null,-29386,null,-86]
[null,"Aufnahme langfristiger Kredite",null,null,null,null,125,null,10500]
[null,"Rückzahlung langfristiger Kredite",null,null,null,null,-1914,null,-90]
[null,"Rückzahlungen unter Leasingverträgen",null,null,null,null,-80,null,-686]
[null,"Erlöse aus Sale/Leaseback Transaktion",null,null,null,null,980,null,2681]
[null,null,null,null,"Netto-Kapitalzufluss aus Finanzierungstätigkeit",null,{"$f":"SUM(G42:G48)","v":83805},null,{"$f":"SUM(I42:I48)","v":15481}]
["Auswirkung von Wechselkursänderungen",null,null,null,null,null,-10,null,23]
["Netto-Erhöhung (Verringerung) der liquiden Mittel",null,null,null,null,null,{"$f":"+G34+G40+G49+G50-1","v":66011},null,{"$f":"+I34+I40+I49+I50","v":-44588}]
["Liquide Mittel am Jahresbeginn",null,null,null,null,null,168,null,66179]
["Liquide Mittel am Jahresende",null,null,null,null,null,{"$f":"+G51+G52","v":66179},null,{"$f":"+I51+I52","v":21591}]
[]
["Ergänzende Angaben zum Cash Flow:"]
[null,"gezahlte Zinsen",null,null,null,null,361.99465188692267,null,850]
[null,"gezahlte Steuern vom Einkommen und Ertrag",null,null,null,null,1012.3579247685126,null,1265]
[]
["Nicht zahlungswirksame Investitions- und Finanzierungstätigkeiten"]
[null,"Umwandlung der Kapitalrücklage in Grundkapital",null,null,null,null,3748.7920729306738,null,0]
[null,"Umwandlung Verbindlichkeiten für deferred shares in Grundkapital",null,null,null,null,199.91512554772143,null,0]
[null,"Umwandlung Verbindlichkeiten für deferred shares in Kapitalrücklage",null,null,null,null,399.83025109544286,null,0]
[null,"Umbuchung von Vorratsvermögen in Sachanlagevermögen",null,null,null,null,161,null,369]
[null,"Umbuchung von Forderungen aus Lieferungen und Leistungen"]
[null,null,"in Finanzanlagen",null,null,null,0,null,6260]
[]
[]
["Auf die nachfolgenden Erläuterungen im Anhang wird verwiesen"]

{"sheet":"CF Deutsch","index":1,"n_rows":92,"n_cols":9,"rows_kept":92,"cut":false,"hidden":false,"merged":[[71,1,71,4],[70,1,70,4],[2,0,2,8],[1,0,1,8],[68,1,68,4],[56,1,56,4],[30,1,30,4],[69,1,69,4],[59,2,59,4],[60,2,60,4]]}
[]
["Carl Zeiss Meditec AG"]
["Konzern-Kapitalflussrechnung (IFRS) 1. Oktober 2013 bis 31. März 2014"]
[]
[null,null,null,null,null,null,"Geschäftsjahr 2013/2014",null,"Geschäftsjahr 2012/2013*"]
[null,null,null,null,null,null,"1. Oktober 2013 -",null,"1. Oktober 2012 -"]
[null,null,null,null,null,"Anhang","31. März 2014",null,"31. März 2013"]
[null,null,null,null,null,null,"€ Tsd.",null,{"$f":"+G8","v":"€ Tsd."}]
[]
["Cashflow aus der gewöhnlichen Geschäftstätigkeit:"]
[]
[null,"Konzernergebnis",null,null,null,null,44147,null,46912]
[]
[null,"Anpassung zur Überleitung des Konzernergebnisses"]
[null,"zur Nettoveränderung der liquiden Mittel aus laufender Geschäftstätigkeit:"]
[]
[null,"Ertragsteueraufwand",null,null,null,"(8)",22355,null,23074]
[null,"Ertrag aus der Veräußerung Mikroskopie-Geschäft Optronik",null,null,null,null,-146,null,0]
[null,"Zinserträge / Zinsaufwendungen",null,null,null,"(7)",2223,null,1541]
[null,"Ergebnis aus At-Equity bewerteten Finanzanlagen",null,null,null,"(7)",null,null,0]
[null,"Ergebnis aus sonstigen Beteiligungen",null,null,null,"(7)",null,null,0]
[null,"Abschreibungen",null,null,null,"(12) (13)",9348,null,8531]
[null,"Wertaufholungen",null,null,null,"(13)",null,null,0]
[null,"Abschreibungen auf Finanzanlagen",null,null,null,"(7)",null,null,0]
[null,"Gewinne/Verluste aus Abgang/Abwertung von Anlagevermögen",null,null,null,null,61,null,-40]
[null,"Erhaltene Dividenden",null,null,null,null,null,null,0]
[null,"Erhaltene Zinsen",null,null,null,null,928,null,2234]
[null,"Gezahlte Zinsen",null,null,null,null,-620,null,-910]
[null,"Erstattete Ertragsteuern",null,null,null,null,1217,null,1608]
[null,"Gezahlte Ertragsteuern",null,null,null,null,-30170,null,-22504]
[null,"Sonstige zahlungsunwirksame Erträge",null,null,null,null,-1327,null,0]
[]
[null,"Veränderungen des Working Capitals:"]
[]
[null,null,"Forderungen aus Lieferungen und Leistungen",null,null,"(18)",-1399,null,-23555]
[null,null,"Vorräte",null,null,"(17)",-11923,null,-11895]
[null,null,"Sonstige Vermögenswerte",null,null,"(16) (19) (20)",-6319,null,-5234]
[null,null,"Verbindlichkeiten aus Lieferungen und Leistungen",null,null,null,-8517,null,-4742]
[null,null,"Ertragsteuerverbindlichkeiten",null,null,null,null,null,0]
[null,null,"Rückstellungen und finanzielle Verbindlichkeiten",null,null,"(23) (24) (26)",2320,null,3395]
[null,null,"Sonstige Verbindlichkeiten",null,null,"(27)",130,null,-224]
[]
[null,"Gesamte Anpassungen",null,null,null,null,{"$f":"SUM(G17:G42)","v":-21839},null,{"$f":"SUM(I17:I42)","v":-28721}]
[null,"Netto-Kapitalzufluss aus der gewöhnlichen Geschäftstätigkeit",null,null,null,null,{"$f":"+G12+G43","v":22308},null,{"$f":"+I12+I43","v":18191}]
[]
["Cashflow aus der Investitionstätigkeit:"]
[]
[null,"Veränderung liquide Mittel mit Verfügungsbeschränkung",null,null,null,null,0,null,0]
[null,"Investitionen in Sachanlagen",null,null,null,"(13)",-4040,null,-3206]
[null,"Investitionen in sonstige immaterielle Vermögenswerte",null,null,null,"(12)",-2242,null,-579]
[null,"Investitionen in Planvermögen",null,null,null,"(24)",null,null,0]
[null,"Erlöse aus dem Verkauf von Anlagevermögen",null,null,null,null,411,null,151]
[null,"Erlöse aus der Liquidation von At-Equity Beteiligungen",null,null,null,null,null,null,0]
[null,"Einzahlungen aus Festgeldanlagen",null,null,null,null,140000,null,120000]
[null,"Auszahlungen für Festgeldanlagen",null,null,null,null,-118000,null,-140000]
[null,"Verkauf von Wertpapieren",null,null,null,"(28)"]
[null,"Erwerb des chirurgischen Geschäftes (Carl Zeiss Surgical GmbH, Carl Zeiss Surgical Inc.) gegen Gewährung von Aktien"]
[null,"Erwerb IOL/ OVD - Geschäftes IMEX Clinic S.L., Spanien",null,null,null,"(3)",-716,null,-1907]
[null,"Erwerb konsolidierter Unternehmen / Geschäftsbetriebe abzgl. erhaltener Finanzmittel",null,null,null,"(3)"]
[null,null,"(Optronik A.S., Türkei:",null,null,null,-10800,null,0]
[null,null,"Aaren Scientific Inc., USA:)",null,null,null,-51206,null,0]
[null,"Einzahlungen aus der Veräußerung des Mikroskopie-Geschäftes der Optronik",null,null,null,null,2208,null,0]
[]
[null,"Netto-Kapitalabfluss aus der Investitionstätigkeit",null,null,null,null,{"$f":"SUM(G48:G62)","v":-44385},null,{"$f":"SUM(I48:I61)","v":-25541}]
[]
["Cashflow aus der Finanzierungstätigkeit:"]
[null,"Aufnahme/(Rückzahlung) der kurzfristigen Kredite",null,null,null,null,-101,null,-22]
[null,"Aufnahme/(Rückzahlung) der langfristigen Kredite",null,null,null,"(25)",-277,null,-254]
[null,"Rückzahlungen von kurzfristigen Darlehen von nahe stehenden Unternehmen",null,null,null,"(35)"]
[null,"Auszahlung aus der Gewährung kurzfristigen Darlehen an nahe stehenden Unternehmen"]
[null,"Rückzahlungen von langfristigen Darlehen von nahe stehenden Unternehmen",null,null,null,"(26) (35)"]
[null,"Einzahlungen aus der Übernahme von Pensionsverpflichtungen durch die Carl Zeiss Meditec Japan"]
[null,"(Zunahme)/Abnahme der Forderungen aus Finanzausgleich",null,null,null,"(2t) (34)",64807,null,44314]
[null,"Zunahme/(Abnahme) der Verbindlichkeiten aus Finanzausgleich",null,null,null,"(2t) (34)",840,null,-4207]
[null,"Rückzahlung von Wandelschuldverschreibungen der Ioltech"]
[null,"Zunahme/(Abnahme) der Verbindlichkeiten aus Finanzierungsleasing",null,null,null,"(29)",-890,null,-901]
[null,"Einnahmen aus Kapitalerhöhung",null,null,null,"(24)"]
[null,"Kosten der Kapitalerhöhung (vor Steuern)",null,null,null,"(24)"]
[null,"Dividendenzahlung an Minderheitsaktionäre der Carl Zeiss Meditec Co. Ltd. (Japan)",null,null,null,"(13)"]
[null,"Dividendenzahlung an die Aktionäre der Carl Zeiss Meditec AG",null,null,null,"(10)",-36589,null,-32524]
[null,"Erwerb von Anteilen nicht-beherrschender Gesellschafter"]
[]
[null,"Netto-Kapitalzufluss/(-abfluss) aus der Finanzierungstätigkeit",null,null,null,null,{"$f":"SUM(G66:G82)","v":27790},null,{"$f":"SUM(I66:I82)","v":6406}]
[]
["Einfluss von Wechselkursänderungen auf Zahlungsmittel und Zahlungsmitteläquivalente",null,null,null,null,null,-282,null,-968]
["Zunahme/(Abnahme) der Zahlungsmittel und Zahlungsmitteläquivalente",null,null,null,null,null,{"$f":"+G44+G64+G83+G85","v":5431},null,{"$f":"+I44+I64+I83+I85","v":-1912}]
["Zahlungsmittel und Zahlungsmitteläquivalente am Beginn des Berichtszeitraumes",null,null,null,null,"(21)",6286,null,9526]
["Zahlungsmittel und Zahlungsmitteläquivalente am Ende des Berichtszeitraumes",null,null,null,null,"(21)",{"$f":"+G86+G87","v":11717},null,{"$f":"+I86+I87","v":7614}]
[]
[]
["* Das Vorjahr wurde aufgrund des geänderten IAS 19 angepasst."]
["Der nachfolgende Konzernanhang ist integraler Bestandteil des ungeprüften Konzernabschlusses."]

{"sheet":"CF Englisch","index":2,"n_rows":92,"n_cols":9,"rows_kept":92,"cut":false,"hidden":false,"merged":[[2,0,2,8],[1,0,1,8],[56,1,56,4],[71,1,71,4],[30,2,30,5],[59,2,59,4],[60,2,60,4]]}
[]
["Carl Zeiss Meditec AG"]
["Consolidated statement of cash flows (IFRS) for the period \nfrom 1 October 2013 to 31 March 2014"]
[]
[null,null,null,null,null,null,"Financial year 2013/2014",null,"Financial year 2012/2013*"]
[null,null,null,null,null,null,"1 October 2013 -",null,"1 October 2012 -"]
[null,null,null,null,null,"Note","31 March 2014",null,"31 March 2013"]
[null,null,null,null,null,null,"€ '000",null,{"$f":"+G8","v":"€ '000"}]
[]
["Cash flows from operating activities:",null,null,null,null,{"$f":"IF('CF Deutsch'!F10<>\"\",'CF Deutsch'!F10,\"\")","v":""}]
[null,null,null,null,null,{"$f":"IF('CF Deutsch'!F11<>\"\",'CF Deutsch'!F11,\"\")","v":""}]
[null,"Net income",null,null,null,{"$f":"IF('CF Deutsch'!F12<>\"\",'CF Deutsch'!F12,\"\")","v":""},{"$f":"+'CF Deutsch'!G12","v":44147},null,{"$f":"+'CF Deutsch'!I12","v":46912}]
[null,null,null,null,null,{"$f":"IF('CF Deutsch'!F13<>\"\",'CF Deutsch'!F13,\"\")","v":""}]
[null,"Adjustments to reconcile net income to net cash provided by / (used in)",null,null,null,{"$f":"IF('CF Deutsch'!F14<>\"\",'CF Deutsch'!F14,\"\")","v":""}]
[null,"operating activities",null,null,null,{"$f":"IF('CF Deutsch'!F15<>\"\",'CF Deutsch'!F15,\"\")","v":""}]
[null,null,null,null,null,{"$f":"IF('CF Deutsch'!F16<>\"\",'CF Deutsch'!F16,\"\")","v":""}]
[null,null,"Income tax expenses",null,null,{"$f":"IF('CF Deutsch'!F17<>\"\",'CF Deutsch'!F17,\"\")","v":"(8)"},{"$f":"+'CF Deutsch'!G17","v":22355},null,{"$f":"+'CF Deutsch'!I17","v":23074}]
[null,null,"Result from carve-out of microscopy business of Optronik A.S.",null,null,null,{"$f":"+'CF Deutsch'!G18","v":-146},null,{"$f":"+'CF Deutsch'!I18","v":0}]
[null,null,"Interest income / expenses ",null,null,{"$f":"+'CF Deutsch'!F19","v":"(7)"},{"$f":"+'CF Deutsch'!G19","v":2223},null,{"$f":"+'CF Deutsch'!I19","v":1541}]
[null,null,"Results from investments accounted for using the equity method",null,null,{"$f":"+'CF Deutsch'!F20","v":"(7)"},{"$f":"+'CF Deutsch'!G20","v":0},null,{"$f":"+'CF Deutsch'!I20","v":0}]
[null,null,"Result from other participations",null,null,{"$f":"+'CF Deutsch'!F21","v":"(7)"},{"$f":"+'CF Deutsch'!G21","v":0},null,{"$f":"+'CF Deutsch'!I21","v":0}]
[null,null,"Depreciation and amortisation",null,null,{"$f":"IF('CF Deutsch'!F22<>\"\",'CF Deutsch'!F22,\"\")","v":"(12) (13)"},{"$f":"+'CF Deutsch'!G22","v":9348},null,{"$f":"+'CF Deutsch'!I22","v":8531}]
[null,null,"Appreciation and write-ups",null,null,{"$f":"IF('CF Deutsch'!F23<>\"\",'CF Deutsch'!F23,\"\")","v":"(13)"},{"$f":"+'CF Deutsch'!G23","v":0},null,{"$f":"+'CF Deutsch'!I23","v":0}]
[null,null,"Impairment of financial assets",null,null,{"$f":"IF('CF Deutsch'!F24<>\"\",'CF Deutsch'!F24,\"\")","v":"(7)"},{"$f":"'CF Deutsch'!G24","v":0},null,{"$f":"'CF Deutsch'!I24","v":0}]
[null,null,"Gains / losses on disposal of fixed assets ",null,null,{"$f":"IF('CF Deutsch'!F25<>\"\",'CF Deutsch'!F25,\"\")","v":""},{"$f":"+'CF Deutsch'!G25","v":61},null,{"$f":"+'CF Deutsch'!I25","v":-40}]
[null,null,"Dividends received",null,null,{"$f":"IF('CF Deutsch'!F26<>\"\",'CF Deutsch'!F26,\"\")","v":""},{"$f":"+'CF Deutsch'!G26","v":0},null,{"$f":"+'CF Deutsch'!I26","v":0}]
[null,null,"Interest received",null,null,{"$f":"IF('CF Deutsch'!F27<>\"\",'CF Deutsch'!F27,\"\")","v":""},{"$f":"+'CF Deutsch'!G27","v":928},null,{"$f":"+'CF Deutsch'!I27","v":2234}]
[null,null,"Interest paid",null,null,{"$f":"IF('CF Deutsch'!F28<>\"\",'CF Deutsch'!F28,\"\")","v":""},{"$f":"+'CF Deutsch'!G28","v":-620},null,{"$f":"+'CF Deutsch'!I28","v":-910}]
[null,null,"Income tax reimbursement",null,null,null,{"$f":"+'CF Deutsch'!G29","v":1217},null,{"$f":"+'CF Deutsch'!I29","v":1608}]
[null,null,"Income taxes paid",null,null,{"$f":"IF('CF Deutsch'!F30<>\"\",'CF Deutsch'!F30,\"\")","v":""},{"$f":"+'CF Deutsch'!G30","v":-30170},null,{"$f":"+'CF Deutsch'!I30","v":-22504}]
[null,null,"Other non-scash income",null,null,null,{"$f":"+'CF Deutsch'!G31","v":-1327},null,{"$f":"+'CF Deutsch'!I31","v":0}]
[]
[null,"Changes in working capital:",null,null,null,{"$f":"IF('CF Deutsch'!F33<>\"\",'CF Deutsch'!F33,\"\")","v":""}]
[null,null,null,null,null,{"$f":"IF('CF Deutsch'!F34<>\"\",'CF Deutsch'!F34,\"\")","v":""}]
[null,null,"Trade receivables",null,null,{"$f":"IF('CF Deutsch'!F35<>\"\",'CF Deutsch'!F35,\"\")","v":"(18)"},{"$f":"+'CF Deutsch'!G35","v":-1399},null,{"$f":"+'CF Deutsch'!I35","v":-23555}]
[null,null,"Inventories",null,null,{"$f":"IF('CF Deutsch'!F36<>\"\",'CF Deutsch'!F36,\"\")","v":"(17)"},{"$f":"+'CF Deutsch'!G36","v":-11923},null,{"$f":"+'CF Deutsch'!I36","v":-11895}]
[null,null,"Other assets",null,null,{"$f":"IF('CF Deutsch'!F37<>\"\",'CF Deutsch'!F37,\"\")","v":"(16) (19) (20)"},{"$f":"+'CF Deutsch'!G37","v":-6319},null,{"$f":"+'CF Deutsch'!I37","v":-5234}]
[null,null,"Trade payables",null,null,{"$f":"IF('CF Deutsch'!F38<>\"\",'CF Deutsch'!F38,\"\")","v":""},{"$f":"+'CF Deutsch'!G38","v":-8517},null,{"$f":"+'CF Deutsch'!I38","v":-4742}]
[null,null,"Income tax liabilities","Erhöhung Vorräte",null,{"$f":"IF('CF Deutsch'!F39<>\"\",'CF Deutsch'!F39,\"\")","v":""},{"$f":"+'CF Deutsch'!G39","v":0},null,{"$f":"+'CF Deutsch'!I39","v":0}]
[null,null,"Provisions and financial liabilities",null,null,{"$f":"IF('CF Deutsch'!F40<>\"\",'CF Deutsch'!F40,\"\")","v":"(23) (24) (26)"},{"$f":"+'CF Deutsch'!G40","v":2320},null,{"$f":"+'CF Deutsch'!I40","v":3395}]
[null,null,"Other liabilities",null,null,{"$f":"IF('CF Deutsch'!F41<>\"\",'CF Deutsch'!F41,\"\")","v":"(27)"},{"$f":"+'CF Deutsch'!G41","v":130},null,{"$f":"+'CF Deutsch'!I41","v":-224}]
[]
[null,"Total adjustments",null,null,null,{"$f":"IF('CF Deutsch'!F43<>\"\",'CF Deutsch'!F43,\"\")","v":""},{"$f":"+'CF Deutsch'!G43","v":-21839},null,{"$f":"+'CF Deutsch'!I43","v":-28721}]
[null,"Net cash provided by operating activities",null,null,null,{"$f":"IF('CF Deutsch'!F44<>\"\",'CF Deutsch'!F44,\"\")","v":""},{"$f":"+'CF Deutsch'!G44","v":22308},null,{"$f":"+'CF Deutsch'!I44","v":18191}]
[null,null,null,null,null,{"$f":"IF('CF Deutsch'!F45<>\"\",'CF Deutsch'!F45,\"\")","v":""}]
["Cash flows from investing activities:",null,null,null,null,{"$f":"IF('CF Deutsch'!F46<>\"\",'CF Deutsch'!F46,\"\")","v":""}]
[null,null,null,null,null,{"$f":"IF('CF Deutsch'!F47<>\"\",'CF Deutsch'!F47,\"\")","v":""}]
[null,"Change of restricted cash",null,null,null,{"$f":"IF('CF Deutsch'!F48<>\"\",'CF Deutsch'!F48,\"\")","v":""},{"$f":"+'CF Deutsch'!G48","v":0},null,{"$f":"+'CF Deutsch'!I48","v":0}]
[null,"Investment in property, plant and equipment",null,null,null,{"$f":"IF('CF Deutsch'!F49<>\"\",'CF Deutsch'!F49,\"\")","v":"(13)"},{"$f":"+'CF Deutsch'!G49","v":-4040},null,{"$f":"+'CF Deutsch'!I49","v":-3206}]
[null,"Investment in intangible assets",null,null,null,{"$f":"IF('CF Deutsch'!F50<>\"\",'CF Deutsch'!F50,\"\")","v":"(12)"},{"$f":"+'CF Deutsch'!G50","v":-2242},null,{"$f":"+'CF Deutsch'!I50","v":-579}]
[null,"Investment in plan assets ",null,null,null,{"$f":"IF('CF Deutsch'!F51<>\"\",'CF Deutsch'!F51,\"\")","v":"(24)"},{"$f":"+'CF Deutsch'!G51","v":0},null,{"$f":"+'CF Deutsch'!I51","v":0}]
[null,"Proceeds from fixed assets",null,null,null,{"$f":"IF('CF Deutsch'!F52<>\"\",'CF Deutsch'!F52,\"\")","v":""},{"$f":"'CF Deutsch'!G52","v":411},null,{"$f":"+'CF Deutsch'!I52","v":151}]
[null,"Proceeds from liquidation of investments accounted for using the equity method",null,null,null,{"$f":"IF('CF Deutsch'!F53<>\"\",'CF Deutsch'!F53,\"\")","v":""},{"$f":"'CF Deutsch'!G53","v":0},null,{"$f":"+'CF Deutsch'!I53","v":0}]
[null,"Proceeds from fixed term deposits",null,null,null,{"$f":"IF('CF Deutsch'!F54<>\"\",'CF Deutsch'!F54,\"\")","v":""},{"$f":"'CF Deutsch'!G54","v":140000},null,{"$f":"+'CF Deutsch'!I54","v":120000}]
[null,"Investments in fixed term deposits",null,null,null,{"$f":"IF('CF Deutsch'!F55<>\"\",'CF Deutsch'!F55,\"\")","v":""},{"$f":"'CF Deutsch'!G55","v":-118000},null,{"$f":"+'CF Deutsch'!I55","v":-140000}]
[null,"Sale of securities",null,null,null,{"$f":"IF('CF Deutsch'!#REF!<>\"\",'CF Deutsch'!#REF!,\"\")","v":{"$error":"#REF!"}},{"$f":"'CF Deutsch'!G56","v":0},null,{"$f":"+'CF Deutsch'!I56","v":0}]
[null,"Acquisition of the surgical business (Carl Zeiss Surgical GmbH, Carl Zeiss Surgical Inc.) against grant of shares",null,null,null,{"$f":"IF('CF Deutsch'!F56<>\"\",'CF Deutsch'!F56,\"\")","v":"(28)"},{"$f":"'CF Deutsch'!G57","v":0},null,{"$f":"+'CF Deutsch'!I57","v":0}]
[null,"Acquisition of IOL/ OVD-business IMEX Clinic S.L., Spain",null,null,null,{"$f":"+'CF Deutsch'!F58","v":"(3)"},{"$f":"+'CF Deutsch'!G58","v":-716},null,{"$f":"+'CF Deutsch'!I58","v":-1907}]
[null,"Acquisition of consolidated companies / businesses, net of cash acquired",null,null,null,{"$f":"IF('CF Deutsch'!#REF!<>\"\",'CF Deutsch'!#REF!,\"\")","v":{"$error":"#REF!"}},{"$f":"'CF Deutsch'!G59","v":0},null,{"$f":"+'CF Deutsch'!I59","v":0}]
[null,null,"(Optronik A.S., Türkei:",null,null,{"$f":"IF('CF Deutsch'!#REF!<>\"\",'CF Deutsch'!#REF!,\"\")","v":{"$error":"#REF!"}},{"$f":"'CF Deutsch'!G60","v":-10800},null,{"$f":"+'CF Deutsch'!I60","v":0}]
[null,null,"Aaren Scientific Inc., USA:)",null,null,null,{"$f":"'CF Deutsch'!G61","v":-51206},null,{"$f":"+'CF Deutsch'!I61","v":0}]
[null,"Carve-out of microscopy business of Optronik A.S.",null,null,null,null,{"$f":"'CF Deutsch'!G62","v":2208},null,{"$f":"+'CF Deutsch'!I62","v":0}]
[]
[null,"Net cash used in investing activities",null,null,null,{"$f":"IF('CF Deutsch'!F64<>\"\",'CF Deutsch'!F64,\"\")","v":""},{"$f":"+'CF Deutsch'!G64","v":-44385},null,{"$f":"+'CF Deutsch'!I64","v":-25541}]
[null,null,null,null,null,{"$f":"IF('CF Deutsch'!F65<>\"\",'CF Deutsch'!F65,\"\")","v":""}]
["Cash flows from financing activities:",null,null,null,null,{"$f":"IF('CF Deutsch'!F66<>\"\",'CF Deutsch'!F66,\"\")","v":""}]
[null,"Proceeds from/(repayment of) short-term debt",null,null,null,{"$f":"IF('CF Deutsch'!F67<>\"\",'CF Deutsch'!F67,\"\")","v":""},{"$f":"+'CF Deutsch'!G67","v":-101},null,{"$f":"+'CF Deutsch'!I67","v":-22}]
[null,"Proceeds from/(repayment of) noncurrent financial liabilities",null,null,null,{"$f":"IF('CF Deutsch'!F68<>\"\",'CF Deutsch'!F68,\"\")","v":"(25)"},{"$f":"+'CF Deutsch'!G68","v":-277},null,{"$f":"+'CF Deutsch'!I68","v":-254}]
[null,"Repayments from current loans from related parties",null,null,null,{"$f":"IF('CF Deutsch'!F69<>\"\",'CF Deutsch'!F69,\"\")","v":"(35)"},{"$f":"+'CF Deutsch'!G69","v":0},null,{"$f":"+'CF Deutsch'!I69","v":0}]
[null,"Payment from granting of current loans to related parties",null,null,null,null,null,null,{"$f":"+'CF Deutsch'!I70","v":0}]
[null,"Repayments from noncurrent loans from related parties",null,null,null,{"$f":"IF('CF Deutsch'!F71<>\"\",'CF Deutsch'!F71,\"\")","v":"(26) (35)"},{"$f":"+'CF Deutsch'!G71","v":0},null,{"$f":"+'CF Deutsch'!I71","v":0}]
[null,"Cash inflow from transfer of provisions to Carl Zeiss Meditec Japan Co. Ltd.",null,null,null,null,{"$f":"+'CF Deutsch'!G72","v":0},null,{"$f":"+'CF Deutsch'!I72","v":0}]
[null,"(Increase) / decrease in treasury receivables",null,null,null,{"$f":"IF('CF Deutsch'!F73<>\"\",'CF Deutsch'!F73,\"\")","v":"(2t) (34)"},{"$f":"'CF Deutsch'!G73","v":64807},null,{"$f":"'CF Deutsch'!I73","v":44314}]
[null,"Increase / (decrease) in treasury payables",null,null,null,{"$f":"+'CF Deutsch'!F74","v":"(2t) (34)"},{"$f":"+'CF Deutsch'!G74","v":840},null,{"$f":"'CF Deutsch'!I74","v":-4207}]
[null,"Repayment of convertible bonds issued by Ioltech",null,null,null,{"$f":"IF('CF Deutsch'!F75<>\"\",'CF Deutsch'!F75,\"\")","v":""},{"$f":"'CF Deutsch'!G75","v":0},null,{"$f":"'CF Deutsch'!I75","v":0}]
[null,"Change of leasing liabilities",null,null,null,{"$f":"IF('CF Deutsch'!F76<>\"\",'CF Deutsch'!F76,\"\")","v":"(29)"},{"$f":"+'CF Deutsch'!G76","v":-890},null,{"$f":"+'CF Deutsch'!I76","v":-901}]
[null,"Proceeds from capital increase",null,null,null,{"$f":"IF('CF Deutsch'!F77<>\"\",'CF Deutsch'!F77,\"\")","v":"(24)"},{"$f":"+'CF Deutsch'!G77","v":0},null,{"$f":"+'CF Deutsch'!I77","v":0}]
[null,"Costs from capital increase (net of taxes)",null,null,null,{"$f":"IF('CF Deutsch'!F78<>\"\",'CF Deutsch'!F78,\"\")","v":"(24)"},{"$f":"+'CF Deutsch'!G78","v":0},null,{"$f":"+'CF Deutsch'!I78","v":0}]
[null,"Dividend payments to minority shareholders of Carl Zeiss Meditec Co. Ltd. (Japan)",null,null,null,{"$f":"IF('CF Deutsch'!F79<>\"\",'CF Deutsch'!F79,\"\")","v":"(13)"},{"$f":"+'CF Deutsch'!G79","v":0},null,{"$f":"+'CF Deutsch'!I79","v":0}]
[null,"Dividend payments to shareholders of Carl Zeiss Meditec AG",null,null,null,{"$f":"IF('CF Deutsch'!F80<>\"\",'CF Deutsch'!F80,\"\")","v":"(10)"},{"$f":"+'CF Deutsch'!G80","v":-36589},null,{"$f":"+'CF Deutsch'!I80","v":-32524}]
[null,"Acquisition of non-controlling interests",null,null,null,{"$f":"IF('CF Deutsch'!F81<>\"\",'CF Deutsch'!F81,\"\")","v":""},{"$f":"+'CF Deutsch'!G81","v":0},null,{"$f":"+'CF Deutsch'!I81","v":0}]
[null,null,null,null,null,{"$f":"IF('CF Deutsch'!F82<>\"\",'CF Deutsch'!F82,\"\")","v":""}]
[null,"Net cash provided by/ (used in) financing activities",null,null,null,{"$f":"IF('CF Deutsch'!F83<>\"\",'CF Deutsch'!F83,\"\")","v":""},{"$f":"+'CF Deutsch'!G83","v":27790},null,{"$f":"+'CF Deutsch'!I83","v":6406}]
[null,null,null,null,null,{"$f":"IF('CF Deutsch'!F84<>\"\",'CF Deutsch'!F84,\"\")","v":""}]
["Effect of exchange rate fluctuation on cash and cash equivalents",null,null,null,null,{"$f":"IF('CF Deutsch'!F85<>\"\",'CF Deutsch'!F85,\"\")","v":""},{"$f":"+'CF Deutsch'!G85","v":-282},null,{"$f":"+'CF Deutsch'!I85","v":-968}]
["Net increase / (decrease)  in cash and cash equivalents",null,null,null,null,{"$f":"IF('CF Deutsch'!F86<>\"\",'CF Deutsch'!F86,\"\")","v":""},{"$f":"+'CF Deutsch'!G86","v":5431},null,{"$f":"+'CF Deutsch'!I86","v":-1912}]
["Cash and cash equivalents, beginning of reporting period",null,null,null,null,{"$f":"IF('CF Deutsch'!F87<>\"\",'CF Deutsch'!F87,\"\")","v":"(21)"},{"$f":"+'CF Deutsch'!G87","v":6286},null,{"$f":"+'CF Deutsch'!I87","v":9526}]
["Cash and cash equivalents, end of reporting period",null,null,null,null,{"$f":"IF('CF Deutsch'!F88<>\"\",'CF Deutsch'!F88,\"\")","v":"(21)"},{"$f":"+'CF Deutsch'!G88","v":11717},null,{"$f":"+'CF Deutsch'!I88","v":7614}]
[]
[]
["* The prior-year figures are adjusted due to amended IAS 19 regulations."]
["The following notes to the consolidated financial statements are an integral part of the unaudited consolidated financial statements."]

{"sheet":"CF_AR","index":3,"n_rows":27,"n_cols":8,"rows_kept":27,"cut":false,"hidden":true,"merged":[[0,0,0,7],[1,0,1,7],[2,0,2,7]]}
["Carl Zeiss Meditec AG"]
["selected positions"]
["Consolidated statement of cash flow (US GAAP)"]
[]
[null,null,null,null,null,"1. October 2001 -",null,"1. October 2002 -"]
[null,null,null,null,null,"30. June 2002",null,"30. June 2003"]
[null,null,null,null,null,"Tsd. Euro",null,"Tsd. Euro"]
[]
[]
["Cash flow from operating activities"]
[null,null,"Net income",null,null,{"$f":"+'CF Deutsch'!G12","v":44147},null,{"$f":"+'CF Deutsch'!I12","v":46912}]
[null,null,"Loss on disposal of discontinued operations",null,null,{"$f":"+'CF Deutsch'!#REF!","v":{"$error":"#REF!"}},null,{"$f":"+'CF Deutsch'!#REF!","v":{"$error":"#REF!"}}]
[null,null,"Depreciation and amortisation",null,null,{"$f":"+'CF Deutsch'!G22","v":9348},null,{"$f":"+'CF Deutsch'!I22","v":8531}]
[null,null,"Trade accounts receivable",null,null,{"$f":"+'CF Deutsch'!G35","v":-1399},null,{"$f":"+'CF Deutsch'!I35","v":-23555}]
[null,null,"Inventories",null,null,{"$f":"+'CF Deutsch'!G36","v":-11923},null,{"$f":"+'CF Deutsch'!I36","v":-11895}]
[null,null,"Trade accounts payable",null,null,{"$f":"+'CF Deutsch'!G38","v":-8517},null,{"$f":"+'CF Deutsch'!I38","v":-4742}]
[null,null,"Accrued tax expenses","Erhöhung Vorräte",null,{"$f":"+'CF Deutsch'!G39","v":0},null,{"$f":"+'CF Deutsch'!I39","v":0}]
[null,null,"Other accrued expenses and liabilities","(Erhöhung) / Verringerung der aktiven Rechnungs-",null,{"$f":"+'CF Deutsch'!G40","v":2320},null,{"$f":"+'CF Deutsch'!I40","v":3395}]
[]
["Cash flow from investing activities",null,null,null,null,{"$f":"+'CF Deutsch'!G64","v":-44385},null,{"$f":"+'CF Deutsch'!I64","v":-25541}]
[]
["Cash flow from financing activities"]
[null,"Proceeds from issuance of short-term debt from related parties",null,null,null,{"$f":"+'CF Deutsch'!G69","v":0},null,{"$f":"+'CF Deutsch'!I69","v":0}]
[null,"Increase / (decrease) in liabilities due to Treasury",null,null,null,{"$f":"+'CF Deutsch'!#REF!","v":{"$error":"#REF!"}},null,{"$f":"+'CF Deutsch'!#REF!","v":{"$error":"#REF!"}}]
[null,"(Increase) / decrease in accounts receivable due to Treasury",null,null,null,{"$f":"+'CF Deutsch'!G73","v":64807},null,{"$f":"+'CF Deutsch'!I73","v":44314}]
[]
["Net increase in cash (compared to Oct 1)",null,null,null,null,{"$f":"+'CF Deutsch'!G86","v":5431},null,{"$f":"+'CF Deutsch'!I86","v":-1912}]